on VALBIOTIS (EPA:ALVAL)
Valbiotis signs an exclusive distribution agreement in the Middle East
Valbiotis, a French laboratory specializing in food supplements, announces an exclusive partnership with Mena Nutrition for the distribution of its products in the Middle East. Mena Nutrition, with 20 years of experience, will market Valbiotis products in Saudi Arabia, Lebanon, and Iraq.
This new agreement, following its development in Asia, represents a key milestone for Valbiotis. The products, designed to prevent cardiometabolic imbalances, will benefit from Mena Nutrition's logistical and commercial expertise, without requiring any direct investment from Valbiotis.
Initial revenues are expected by the end of 2026, subject to regulatory approvals. This agreement reinforces Valbiotis' ambitions for international expansion, strengthening its position in high-potential markets. It also demonstrates the company's commitment to responsible and innovative preventive healthcare.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news